Martin & Co. Inc. TN Has $3.84 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Martin & Co. Inc. TN reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 49,114 shares of the company’s stock after selling 2,152 shares during the quarter. Martin & Co. Inc. TN’s holdings in GE HealthCare Technologies were worth $3,840,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. State Street Corp increased its stake in shares of GE HealthCare Technologies by 7.8% in the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company’s stock valued at $1,026,898,000 after buying an additional 733,819 shares in the last quarter. Van ECK Associates Corp increased its stake in shares of GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock valued at $378,520,000 after buying an additional 2,506,417 shares in the last quarter. D1 Capital Partners L.P. bought a new position in GE HealthCare Technologies in the third quarter valued at about $268,159,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in GE HealthCare Technologies by 12.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock valued at $254,422,000 after acquiring an additional 290,019 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent analyst reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Stock Down 1.4 %

Shares of GE HealthCare Technologies stock opened at $92.21 on Monday. The business’s 50 day simple moving average is $84.03 and its 200 day simple moving average is $85.54. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The firm has a market cap of $42.13 billion, a PE ratio of 25.33, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th were given a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend was Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.